• A number of obstacles to uptake of the HPV vaccine in boys include not receiving a
recommendation from a doctor or health care provider, lack of information about the HPV …

Abstract Question In Canada, generally provincial human papillomavirus (HPV) vaccination
programs exist for only the female population. What should I recommend when parents and …

The quadrivalent HPV vaccine (HPV4) is safe and highly efficacious, and can significantly
reduce the burden of HPV-related genital warts and cancers among men, in addition to …

Background: Although already approved for use in males in some jurisdictions, there is little
information about parental attitudes toward having their sons receive the human …

Female-only vaccination programmes for human papillomavirus (HPV) have been
introduced in many countries aimed at the prevention of cervical cancer in women. One HPV …

Prophylactic vaccination against high risk human papilloma virus (HPV) 16 and 18
represents an exciting means of protection against HPV related malignancy. However, this …

The quadrivalent human papillomavirus virus vaccine was recently licensed for use in males
in the United States. This study reviews available published literature on acceptability …

Eurosurveillance | Human papillomavirus vaccination: the United Kingdom’s
recommendation and update on European licensure and efficacy data 1887 Other sites …

The human papillomavirus (HPV) infects approximately 550,000 Canadians annually.
Cancers of the cervix, mouth, anus, throat and neck are caused by various strains of the …

Background: In October 2009, a quadrivalent vaccine for human papillomavirus (HPV) was
licensed in the United States for males aged 9 to 26 years. The attitudes and beliefs of …